Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ENSCABUS

Ensysce Biosciences, Inc.

ENSC · $0.47

55Fair

Arbutus Biopharma Corp

ABUS · $4.20

78Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ENSC

55/100

ABUS

78/100

Quality

Is it a profitable, well-run business?

ENSC

4.0/10

ABUS

10.0/10

Growth

Is the company growing?

ENSC

5.0/10

ABUS

8.0/10

Valuation

Is the price reasonable? (higher = cheaper)

ENSC

3.3/10

ABUS

7.5/10

Risk

How risky are the shares? (higher = lower risk)

ENSC

4.2/10

ABUS

7.3/10

Momentum

Is the share price trending up?

ENSC

6.9/10

ABUS

5.5/10

Financial strength

Is the balance sheet healthy?

ENSC

2.3/10

ABUS

9.0/10

The balanced view

Model-generated

Ensysce Biosciences, Inc.

This company has a mixed profile, with supportive analyst views and a positive price trend, although its balance sheet looks stretched.

Leads on: momentum

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: balance sheet is stretched (Altman Z-Score: -81.88)

Arbutus Biopharma Corp

This company scores well across most areas, with strong profitability and supportive analyst views.

Leads on: quality, growth, valuation, risk, financial strength

Best feature: strong profitability (Return on equity (TTM): 91.0%)

Watch out: weakest area: price momentum (Signal consensus: Strong Sell)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.